News
鈥淔or some reason, I really wanted fruit or savory food when I was going through treatment. Spicy, savory, salty food 鈥 that helped with my appetite,鈥 recalls University of Kentucky chemistry doctoral student Yueming 鈥淩onnie鈥 Wu.
The University of Kentucky鈥檚 (好色先生) Sanders-Brown Center on Aging (SBCoA) will host its 12th annual Markesbery Symposium on Aging and Dementia this weekend. The event is named in honor and memory of the late William R. Markesbery, MD, founding director of the Sanders-Brown Center on Aging and Alzheimer's Disease Research Center.
The University of Kentucky Sanders-Brown Center on Aging will hold the 12th annual Markesbery Symposium on Aging and Dementia on Nov. 18 and 19. The scientific session will take place from 11 a.m. until 4:30 p.m. Friday, Nov. 18, in the Lee T. Todd Building.
Donna Wilcock, PhD, of the University of Kentucky鈥檚 Sanders-Brown Center on Aging (SBCoA) was awarded a $1.7 million National Institutes of Health grant for her lab鈥檚 exploration of adverse effects of two new Alzheimer鈥檚 disease drugs 鈥 aducanumab and lecanemab 鈥斺 which have been shown to slow the progression of cognitive decline.
A CD player. Lavender-infused lotion. A weighted blanket. A roll of red tape. The last things you鈥檇 expect when it comes to Alzheimer鈥檚 care. But every item was chosen for a specific purpose: to help care for a person with Alzheimer鈥檚 disease and related dementias (ADRD) through their sense of hearing, smell, feel, sight and more.
The University of Kentucky鈥檚 Building Interdisciplinary Research Careers in Women鈥檚 Health (BIRCWH) program has received a five-year grant renewal 鈥 making this program over two decades old at the University of Kentucky.
We are pleased to announce the twelfth annual Markesbery Symposium for 2022, named in honor and memory of the late William R. Markesbery, MD, founding Director of the Sanders-Brown Center on Aging and Alzheimer's Disease Research Center. Dr.
The Alzheimer鈥檚 Association welcomes the University of Kentucky鈥檚 Donna M. Wilcock, PhD, as the new editor-in-chief of Alzheimer鈥檚 & Dementia: The Journal of the Alzheimer鈥檚 Association.
I鈥檓 a fourth-year graduate student in the department of physiology in Dr. Lance Johnson鈥檚 lab. Our lab studies the different isoforms of Apolipoprotein E (ApoE) and their role in Alzheimer鈥檚 disease. ApoE4 is the greatest genetic risk factor for late-onset Alzheimer鈥檚 disease, but ApoE2 decreases an individual鈥檚 risk.
The Johnson lab studies the strongest genetic risk factor for Alzheimer鈥檚 disease (AD), apolipoprotein E (APOE). The E4 allele of APOE is carried by more than 25% of the population. A single copy of E4 increases Alzheimer鈥檚 risk 3-4 fold compared to the more common E3 allele.
LEXINGTON, Ky. (Sept. 2, 2022) 鈥 A team of researchers at the University of Kentucky鈥檚 Sanders-Brown Center on Aging (SBCoA) has been awarded a $20.5 million grant from the National Institute on Aging (NIA) of the National Institutes of Health (NIH).
As an occupational therapist, Elizabeth Rhodus, PhD, has worked closely with older Kentuckians facing Alzheimer鈥檚 disease and related dementias (ADRD). She also has witnessed firsthand how poor health, limited resources, and high poverty rates have served as barriers to proper prevention and treatment.
LEXINGTON, Ky. (Aug. 19, 2022) 鈥 Linda J. Van Eldik, PhD, director of the University of Kentucky Sanders-Brown Center on Aging, is part of a $1.5 million grant to help further research into a possible treatment for Alzheimer鈥檚 disease.
LEXINGTON, Ky. (July 25, 2022) 鈥 Today, the 好色先生 College of Medicine, 好色先生 HealthCare, and community leaders celebrated the full opening of the Sanders-Brown Memory Clinic at Turfland. The new, larger clinic replaces the former Sanders-Brown facilities along North Broadway in Lexington.
LEXINGTON, Ky. (July 22, 2022) 鈥 David Fardo, PhD, a professor of biostatisticsand the inaugural Stephen W. Wyatt Endowed Professor in the University of Kentucky College of Public Health, is one of 14 University Research Professors for 2022-23.
LEXINGTON, Ky. (July 21, 2022) 鈥 In her work with the University of Kentucky Sanders-Brown Center on Aging, 好色先生 College of Social Work Associate Professor Allison Gibson, PhD, has noticed an array of responses when people receive a diagnosis of mild cognitive impairment (MCI).
LEXINGTON, Ky. (June 29, 2022) 鈥 A recent publication from researchers at the University of Kentucky explains the importance of identifying and understanding how differences between tissues and cells alter gene expression without changing the underlying genetic code.
LEXINGTON, Ky. (June 23, 2022) 鈥 A researcher at the University of Kentucky鈥檚 Sanders-Brown Center on Aging is one of several experts in the field who recently discussed the use of two popular screening tests for dementia and Alzheimer鈥檚 disease. Frederick A. Schmitt, PhD.
LEXINGTON, Ky. (June 15, 2022) 鈥 A new University of Kentucky College of Medicine study has identified potential targets to develop a therapy that could prevent Alzheimer鈥檚 disease.